379 related articles for article (PubMed ID: 16207327)
21. Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study.
Pamuk GE; Turgut B; Pamuk ON; Vural O; Demir M; Cakir N
Blood Coagul Fibrinolysis; 2007 Jun; 18(4):297-302. PubMed ID: 17473568
[TBL] [Abstract][Full Text] [Related]
22. Endothelial and adrenergic dysfunction in Raynaud's phenomenon and scleroderma.
Freedman RR; Girgis R; Mayes MD
J Rheumatol; 1999 Nov; 26(11):2386-8. PubMed ID: 10555897
[TBL] [Abstract][Full Text] [Related]
23. Discrepancy between simultaneous digital skin microvascular and brachial artery macrovascular post-occlusive hyperemia in systemic sclerosis.
Roustit M; Simmons GH; Baguet JP; Carpentier P; Cracowski JL
J Rheumatol; 2008 Aug; 35(8):1576-83. PubMed ID: 18597404
[TBL] [Abstract][Full Text] [Related]
24. Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
Gardinali M; Pozzi MR; Bernareggi M; Montani N; Allevi E; Catena L; Cugno M; Bottasso B; Stabilini R
J Rheumatol; 2001 Apr; 28(4):786-94. PubMed ID: 11327251
[TBL] [Abstract][Full Text] [Related]
25. Sodium nitroprusside iontophoresis on the finger pad does not consistently increase skin blood flow in healthy controls and patients with systemic sclerosis.
Roustit M; Blaise S; Cracowski JL
Microvasc Res; 2009 May; 77(3):260-4. PubMed ID: 19272396
[TBL] [Abstract][Full Text] [Related]
26. Abnormal responses to endothelial agonists in Raynaud's phenomenon and scleroderma.
Freedman RR; Girgis R; Mayes MD
J Rheumatol; 2001 Jan; 28(1):119-21. PubMed ID: 11196511
[TBL] [Abstract][Full Text] [Related]
27. Laser Doppler velocimetry of fingertips during heat provocation in normals and in patients with Raynaud's phenomenon.
Wollersheim H; Reyenga J; Thien T
Scand J Clin Lab Invest; 1988 Feb; 48(1):91-5. PubMed ID: 2975399
[TBL] [Abstract][Full Text] [Related]
28. Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with nailfold microvascular impairment.
Rollando D; Bezante GP; Sulli A; Balbi M; Panico N; Pizzorni C; Negrini S; Brunelli C; Barsotti A; Cutolo M; Indiveri F; Ghio M
J Rheumatol; 2010 Jun; 37(6):1168-73. PubMed ID: 20436078
[TBL] [Abstract][Full Text] [Related]
29. Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial.
Dziadzio M; Denton CP; Smith R; Howell K; Blann A; Bowers E; Black CM
Arthritis Rheum; 1999 Dec; 42(12):2646-55. PubMed ID: 10616013
[TBL] [Abstract][Full Text] [Related]
30. Local cold exposure test with a new arterial photoplethysmographic sensor in healthy controls and patients with secondary Raynaud's phenomenon.
Hahn M; Hahn C; Jünger M; Steins A; Zuder D; Klyscz T; Büchtemann A; Rassner G; Blazek V
Microvasc Res; 1999 Mar; 57(2):187-98. PubMed ID: 10049666
[TBL] [Abstract][Full Text] [Related]
31. Effect of temperature and modulators of protein tyrosine kinase activity on the reactivity of isolated venules in secondary Raynaud's phenomenon.
Furspan PB; Mayes MD; Freedman RR
J Rheumatol; 2001 Oct; 28(10):2263-8. PubMed ID: 11669167
[TBL] [Abstract][Full Text] [Related]
32. Postocclusive reactive hyperemia in hand-arm vibration syndrome.
Stoyneva Z
Int J Occup Med Environ Health; 2016; 29(4):659-66. PubMed ID: 27443761
[TBL] [Abstract][Full Text] [Related]
33. Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis.
Hong P; Pope JE; Ouimet JM; Rullan E; Seibold JR
J Rheumatol; 2004 Mar; 31(3):508-13. PubMed ID: 14994396
[TBL] [Abstract][Full Text] [Related]
34. Reproducibility and methodological issues of skin post-occlusive and thermal hyperemia assessed by single-point laser Doppler flowmetry.
Roustit M; Blaise S; Millet C; Cracowski JL
Microvasc Res; 2010 Mar; 79(2):102-8. PubMed ID: 20064535
[TBL] [Abstract][Full Text] [Related]
35. The "distal-dorsal difference" as a possible predictor of secondary Raynaud's phenomenon.
Clark S; Hollis S; Campbell F; Moore T; Jayson M; Herrick A
J Rheumatol; 1999 May; 26(5):1125-8. PubMed ID: 10332978
[TBL] [Abstract][Full Text] [Related]
36. Blunted increase of digital skin vasomotion following acetylcholine and sodium nitroprusside iontophoresis in systemic sclerosis patients.
Rossi M; Bazzichi L; Di Maria C; Franzoni F; Raimo K; Della Rossa A; Santoro G; Bombardieri S
Rheumatology (Oxford); 2008 Jul; 47(7):1012-7. PubMed ID: 18430760
[TBL] [Abstract][Full Text] [Related]
37. Laser Doppler perfusion imaging is useful in the study of Raynaud's phenomenon and improves the capillaroscopic diagnosis.
Rosato E; Borghese F; Pisarri S; Salsano F
J Rheumatol; 2009 Oct; 36(10):2257-63. PubMed ID: 19684154
[TBL] [Abstract][Full Text] [Related]
38. Spectral analysis of laser-Doppler perfusion signal measured during thermal test.
Maniewski R; Leger P; Lewandowski P; Liebert A; Bendayan P; Boccalon H; Bajorski L; Möller KO
Technol Health Care; 1999; 7(2-3):163-9. PubMed ID: 10463305
[TBL] [Abstract][Full Text] [Related]
39. Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis.
Sunderkötter C; Riemekasten G
Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii33-5. PubMed ID: 16987831
[TBL] [Abstract][Full Text] [Related]
40. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
